Regulatory advisors in the US have refused to back GlaxoSmithKline’s Avodart and Merck's Proscar - medicines used to treat enlarged prostates - for the prevention of prostate cancer in men. Regulatory ...

June 18, 2010 (UPDATED June 21, 2010) — The US Food and Drug Administration (FDA) has approved a single-capsule formulation of 0.5-mg dutasteride and 0.4-mg tamsulosin (Jalyn; GlaxoSmithKline) for ...

LONDON, March 23 (Reuters) - GlaxoSmithKline said it would no longer pursue approval for its drug Avodart to reduce the risk of prostate cancer after regulators in the United States and Sweden raised ...

PThey include interferons, interleukin- The lighter for new more effective treatments for post goes on with the site of drugs to block the use of oncogenes, drugs to inhibit cancer depend enzymes and ...

A four-year study of more than 8,000 men between the ages of 50 to 75 who had an elevated risk for developing prostate cancer found that those who took the drug dutasteride (sold as Avodart) were less ...

NEW YORK (Reuters) - U.S. health regulators declined to approve GlaxoSmithKline's Avodart enlarged prostate drug for reducing the risk of prostate cancer in men deemed to be at increased risk, the ...

Can i purchase avodart .5 mg online legally As with finasteride, patients taking dutasteride should be on the medication for one year or prostate cancer in men undergoing Avodart therapy, no ...